Purchase Order 75N93025P00962

Award Date 5/7/25
Potential Completion Date 5/6/26
Potential Value $38K
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD), a global medical technology company. The $37,011.60 contract is for service and maintenance of BD FACS Aria flow cytometry instruments, including Obis lasers, at the agency's facilities in Rockville, Maryland. The contract does not have a set-aside designation. BD...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a maintenance agreement on a FACS Canto II flow cytometer and high throughput sampler. The $91,517.80 contract has a period of performance from August 15, 2022 to March 14, 2027, with annual option years. The equipment is used in daily mission-critical operations within NIAID's...
The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a one-year firm fixed price purchase order to Becton, Dickinson and Company (BD) valued at $36,688.68 for maintenance services on a BD LSRFortessa flow cytometer and FACS Flow Supply System. The contract covers two preventive maintenance inspections per year, unlimited service visits, and priority response time. This is an unrestricted, full and open...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson And Company (BD) for a service agreement to maintain BD flow cytometers and lasers. The $32,457.45 contract has a period of performance from November 21, 2022 to April 21, 2023 and does not include a set-aside designation. BD, a global medical technology company, will...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for base year service and maintenance of a FACSymphony A5 flow cytometer and FACSAria 11-3 laser system. The contract has a ceiling value of $135,677.76 and a period of performance from January 22, 2020 to January 22, 2022, with an initial base year and one option year. There is no...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a FACS ARIA 2 service agreement. The contract has a ceiling value of $58,752.00 and an ultimate completion date of November 30, 2018. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a firm-fixed-price purchase order worth $54,593.64 to Becton, Dickinson and Company (BD) for a one-year maintenance and service agreement for BD Biosciences flow cytometry equipment. The contract, which has no set-aside designation, will run from April 1, 2023, through March 31, 2024. BD, a global medical technology company, is the prime contractor and will provide on-site maintenance and repair...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $125,877.00. The contract is for an annual service agreement to maintain BD's FACS (fluorescence-activated cell sorting) flow machines and accessories used to support biomedical research and clinical applications at NIAID. The contract does not have a set-aside designation. BD is...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for a service agreement covering maintenance and repair of specialized flow cytometry instruments. The one-year contract, valued at $109,796.40, provides parts, labor, and travel for maintaining the agency's FACS Calibur, FACS Aria II, LSR Fortessa, and LSR II instruments. The...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for maintenance and repair services on 2 Facscelesta flow cytometry instruments. The award has a base year from August 29, 2019 to August 28, 2020, plus 4 option years through August 28, 2024, for a potential total value of $217,613.40. The contract was awarded on a full and open basis without a small...

This is a renewed service agreement between the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and Becton, Dickinson and Company (BD), a global medical technology manufacturer, for the maintenance and repair of BD FACS Aria Fusion and BD FACSStation flow cytometry instruments. The fixed-price contract, valued at $38,318.40, has a period of performance through May 6, 2026. The contract was awarded on May 7, 2025 as a firm fixed-price purchase order without any set-aside designation, indicating BD's competitive position in the federal medical technology market. This contract is likely part of BD's broader portfolio of IDIQ contracts and federal grant sub-awards supporting advanced biomedical research and clinical applications across NIH institutes and other government agencies.

Generated 5/6/25, 11:42 AM